JP2011527565A5 - - Google Patents

Download PDF

Info

Publication number
JP2011527565A5
JP2011527565A5 JP2011517318A JP2011517318A JP2011527565A5 JP 2011527565 A5 JP2011527565 A5 JP 2011527565A5 JP 2011517318 A JP2011517318 A JP 2011517318A JP 2011517318 A JP2011517318 A JP 2011517318A JP 2011527565 A5 JP2011527565 A5 JP 2011527565A5
Authority
JP
Japan
Prior art keywords
nucleic acid
breast cancer
marker
allele
linkage disequilibrium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011517318A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011527565A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IS2009/000008 external-priority patent/WO2010004591A2/en
Publication of JP2011527565A publication Critical patent/JP2011527565A/ja
Publication of JP2011527565A5 publication Critical patent/JP2011527565A5/ja
Pending legal-status Critical Current

Links

JP2011517318A 2008-07-07 2009-07-03 乳癌のリスクアセスメントのための遺伝的変異 Pending JP2011527565A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IS8746 2008-07-07
IS8746 2008-07-07
PCT/IS2009/000008 WO2010004591A2 (en) 2008-07-07 2009-07-03 Genetic variants for breast cancer risk assessment

Publications (2)

Publication Number Publication Date
JP2011527565A JP2011527565A (ja) 2011-11-04
JP2011527565A5 true JP2011527565A5 (https=) 2012-08-16

Family

ID=41110719

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011517318A Pending JP2011527565A (ja) 2008-07-07 2009-07-03 乳癌のリスクアセスメントのための遺伝的変異

Country Status (10)

Country Link
US (1) US8951735B2 (https=)
EP (1) EP2313525A2 (https=)
JP (1) JP2011527565A (https=)
KR (1) KR20110036608A (https=)
CN (1) CN102144036B (https=)
AU (1) AU2009269542A1 (https=)
CA (1) CA2729934A1 (https=)
IL (1) IL210504A0 (https=)
NZ (1) NZ590833A (https=)
WO (1) WO2010004591A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011095999A1 (en) * 2010-02-05 2011-08-11 Decode Genetics Ehf Genetic variants for predicting risk of breast cancer
HK1197085A1 (en) * 2011-06-16 2015-01-02 Decode Genetics Ehf Genetic variants for predicting risk of breast cancer
CN102643905B (zh) * 2012-04-01 2014-06-11 周宏灏 焦磷酸测序法检测他莫昔芬个体化用药基因多态性的试剂盒及方法
WO2014119914A1 (ko) * 2013-02-01 2014-08-07 에스케이텔레콤 주식회사 유전자 서열 기반 개인 마커에 관한 정보를 제공하는 방법 및 이를 이용한 장치
KR101770962B1 (ko) * 2013-02-01 2017-08-24 에스케이텔레콤 주식회사 유전자 서열 기반 개인 마커에 관한 정보를 제공하는 방법 및 이를 이용한 장치
WO2014145705A2 (en) 2013-03-15 2014-09-18 Battelle Memorial Institute Progression analytics system
CN103981273B (zh) * 2014-05-30 2017-01-18 复旦大学附属肿瘤医院 一组评估乳腺癌风险的突变基因群及其检测试剂盒
US10395759B2 (en) 2015-05-18 2019-08-27 Regeneron Pharmaceuticals, Inc. Methods and systems for copy number variant detection
CN105069322B (zh) * 2015-07-24 2018-01-12 上海尔云信息科技有限公司 疾病易感风险预测装置
CA3014292A1 (en) 2016-02-12 2017-08-17 Regeneron Pharmaceuticals, Inc. Methods and systems for detection of abnormal karyotypes
CN105586427B (zh) * 2016-03-10 2020-06-19 厦门艾德生物医药科技股份有限公司 检测人类brca1和brca2基因突变的引物、试剂盒及方法
US11332530B2 (en) 2016-09-23 2022-05-17 Memorial Sloan Kettering Cancer Center Determinants of cancer response to immunotherapy
CN106676169B (zh) * 2016-11-15 2021-01-12 上海派森诺医学检验所有限公司 一种用于乳腺癌易感基因brca1和brca2突变检测的杂交捕获试剂盒及其方法
JP2020508643A (ja) * 2017-01-24 2020-03-26 ジェネティック テクノロジーズ リミテッド 乳癌発症リスクの改良された評価法
CN107341347A (zh) * 2017-06-27 2017-11-10 天方创新(北京)信息技术有限公司 基于评分模型对乳腺癌进行风险评分的方法及装置
CN112534070B (zh) * 2018-06-29 2024-07-30 杰克逊实验室 乳腺癌剪接变体
CN108676890B (zh) * 2018-07-12 2022-01-28 吉林大学 一种女性乳腺恶性肿瘤易感性预测试剂盒及系统
US20230170045A1 (en) * 2020-04-20 2023-06-01 Myriad Genetics, Inc. Comprehensive polygenic risk prediction for breast cancer
WO2024085660A1 (ko) * 2022-10-18 2024-04-25 제노플랜 인크 질병 발생 위험도 예측 장치 및 방법
EP4646208A1 (en) 2023-01-06 2025-11-12 Ideaya Biosciences, Inc. Treatment of er+ breast cancer comprising homologous recombination deficiency using parg inhibitor
CN119446277B (zh) * 2024-10-31 2026-03-27 中国人民解放军总医院 分子检测方法、装置、计算机设备、存储介质和程序产品

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US6054270A (en) 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
EP0436597B1 (en) 1988-09-02 1997-04-02 Protein Engineering Corporation Generation and selection of recombinant varied binding proteins
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5288644A (en) 1990-04-04 1994-02-22 The Rockefeller University Instrument and method for the sequencing of genome
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
EP0585287B1 (en) 1990-07-10 1999-10-13 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
CA2405246A1 (en) 1990-12-03 1992-06-11 Genentech, Inc. Enrichment method for variant proteins with alterred binding properties
EP0575485A1 (en) 1991-03-01 1993-12-29 Dyax Corp. Process for the development of binding mini-proteins
DK0580737T3 (da) 1991-04-10 2004-11-01 Scripps Research Inst Heterodimere receptorbiblioteker ved anvendelse af phagemider
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
US6287850B1 (en) 1995-06-07 2001-09-11 Affymetrix, Inc. Bioarray chip reaction apparatus and its manufacture
EP0695941B1 (en) 1994-06-08 2002-07-31 Affymetrix, Inc. Method and apparatus for packaging a chip
US6300063B1 (en) 1995-11-29 2001-10-09 Affymetrix, Inc. Polymorphism detection
EP1736554B1 (en) 1996-05-29 2013-10-09 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
US6429027B1 (en) 1998-12-28 2002-08-06 Illumina, Inc. Composite arrays utilizing microspheres
US20040009481A1 (en) * 2001-06-11 2004-01-15 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer
DE10228081A1 (de) * 2002-06-18 2004-01-08 InViTek Gesellschaft für Biotechnik & Biodesign mbH Verfahren zum Nachweis einer gesteigerten Tumorsuszeptibilität
KR100763902B1 (ko) * 2004-02-20 2007-10-05 삼성전자주식회사 유방암 특이적 단백질, 그를 코딩하는 유전자, 및 상기단백질 또는 유전자를 이용한 유방암의 진단 방법
WO2006063285A2 (en) * 2004-12-10 2006-06-15 Sequenom, Inc. Methods for identifying risk of breast cancer or prostate cancer and treatments thereof
CN101037690B (zh) * 2006-03-16 2011-07-20 国家人口计生委科学技术研究所 具有新的单核苷酸多态性的brca1基因变体和其编码的蛋白质变体
JP5631000B2 (ja) * 2006-10-27 2014-11-26 デコード・ジェネティクス・イーエイチエフ Chr8q24.21上の癌感受性変異体
EA019953B1 (ru) 2007-03-26 2014-07-30 Декоуд Дженетикс Ехф Генетические варианты chr2 и chr16 в качестве маркеров для применения при оценке риска, диагностировании, прогнозировании и лечении рака молочной железы
CA2688312A1 (en) 2007-05-25 2008-12-04 Decode Genetics Ehf. Genetic variants on chr 5p12 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment

Similar Documents

Publication Publication Date Title
JP2011527565A5 (https=)
JP7689557B2 (ja) 相同組換え欠損を推定するための統合された機械学習フレームワーク
Morales Berstein et al. Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study
JP7145907B2 (ja) 疾患細胞不均一性を示す疾患の検出および処置、ならびに通信試験結果のためのシステムおよび方法
Banovich et al. Methylation QTLs are associated with coordinated changes in transcription factor binding, histone modifications, and gene expression levels
Boyle et al. Annotation of functional variation in personal genomes using RegulomeDB
Alazami et al. Mutation in ADAT3, encoding adenosine deaminase acting on transfer RNA, causes intellectual disability and strabismus
CN107423534B (zh) 基因组拷贝数变异的检测方法和系统
KR102384620B1 (ko) 유전적 변이의 비침습 평가를 위한 방법 및 프로세스
JP2011530306A5 (https=)
JP2025106239A (ja) 病原体検出のための配列決定データを使用するためのシステムおよび方法
Kommadath et al. Gene co-expression network analysis identifies porcine genes associated with variation in Salmonella shedding
Ullah et al. Detection of novel infiltrating ductal carcinoma-associated BReast CAncer gene 2 mutations which alter the deoxyribonucleic acid-binding ability of BReast CAncer gene 2 protein
Huang et al. Genome-wide association study on chicken carcass traits using sequence data imputed from SNP array
CN103045739A (zh) 一种拟穴青蟹SNPs分子标记的筛选方法
Lai et al. Speed-mapping quantitative trait loci using microarrays
Xue et al. Genome-wide association study reveals additive and non-additive effects on growth traits in Duroc pigs
Li et al. Incorporating local ancestry improves identification of ancestry-associated methylation signatures and meQTLs in African Americans
EP2973117A2 (en) Electronic medical records system utilizing genetic information
JP2020536585A (ja) 乳癌発症リスクの評価法
Mohindra et al. Development of EST derived SSRs and SNPs as a genomic resource in Indian catfish, Clarias batrachus
Shi et al. Influence of validating the parental origin on the clinical interpretation of fetal copy number variations in 141 core family cases
Halder et al. SNP microarray in FISH negative clinically suspected 22q11. 2 microdeletion syndrome
Rashkin et al. Pan-cancer study detects novel genetic risk variants and shared genetic basis in two large cohorts
Hishida et al. Genome-wide association study of serum prostate-specific antigen levels based on 1000 Genomes imputed data in Japanese: the Japan Multi-Institutional Collaborative Cohort Study